Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 58,782 shares at $88.21 ($5.3M) on 2020-11-10, disclosed to the SEC on 2020-11-12.
Open-market sale of $5.3M EBS by Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.26 | 20,000 | $1.9M | 35.8% |
| 2 | $88.21 | 19,391 | $1.7M | 32.1% |
| 3 | $88.21 | 19,391 | $1.7M | 32.1% |
| Total | $90.61 avg | 58,782 | $5.3M | 100% |
| Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |
| EBS | SELL | 2020-05-01 | $3.0M | — | Filing → |